PhaseV: Funding, Investors & Team (Oct 2026)
PhaseV is using advanced statistical methods and tools to revolutionize the way trials are planned, carried out, and analyzed. By identifying hidden patterns in clinical data, PhaseV extracts practical information that can guide decision making. Their technology enables the creation of adaptive trial designs and ensures seamless execution, resulting in improved efficiency and higher rates of success. PhaseV aims to transform the field of clinical trials by introducing innovative approaches that bring novel treatments to a greater number of people in a more accurate and streamlined way.
PhaseV has raised $65.0M across 2 funding rounds on record, the most recent a Series A of $50.0M announced in May 2025.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
PhaseV Company Profile and Key Stats
Latest funding round on record: May 2025.
PhaseV Funding Rounds
PhaseV raised $15.0M in a Seed announced in Oct 2023.
1.6 years later, a Series A of $50.0M was announced in May 2025.
PhaseV Founders and Leadership Team
Contact details for the PhaseV team: 1 of 2 have an email address on file.
Start 14-day free trial →PhaseV Funding Compared to Other Health Care Startups
PhaseV's latest round of $50.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PhaseV in Health Care and Boston
Companies Similar to PhaseV
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
PhaseV Funding FAQs
What does PhaseV do?
PhaseV is using advanced statistical methods and tools to revolutionize the way trials are planned, carried out, and analyzed. By identifying hidden patterns in clinical data, PhaseV extracts practical information that can guide decision making. Their technology enables the creation of adaptive trial designs and ensures seamless execution, resulting in improved efficiency and higher rates of success. PhaseV aims to transform the field of clinical trials by introducing innovative approaches that bring novel treatments to a greater number of people in a more accurate and streamlined way.
How much funding has PhaseV raised?
PhaseV has raised $65.0M across 2 rounds on record. The most recent is a Series A of $50.0M announced in May 2025.
When did PhaseV last raise funding?
PhaseV's most recent funding round on record is a Series A of $50.0M, announced in May 2025.
Who founded PhaseV?
FundedIQ lists Elad Berkman (Founder), Zvika Orron (Founder) at PhaseV.
Where is PhaseV headquartered?
PhaseV is based in Boston, Massachusetts, United States.
How many employees does PhaseV have?
PhaseV is in the 11-50 employee band.
How does PhaseV's funding compare to other Health Care startups?
PhaseV's latest round of $50.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's PhaseV Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PhaseV is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.